Ecotoxicological risk of pharmaceuticals from wastewater treatment plants in Korea: Occurrence and toxicity to Daphnia magna

Environmental Toxicology and Chemistry

Volumn 25, Issue 1, 2006, Pages 265-271

  Han, Guk H ^a   Hur, Hor G ^a   Kim, Sang D ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Pharmaceuticals; Risk assessment; Toxicity; Wastewater treatment plants

Indexed keywords

BIOASSAY; CHRONOMETERS; ECOLOGY; EFFLUENTS; METABOLITES; RISK ASSESSMENT; TOXICITY; WASTEWATER TREATMENT;

ECOTOXICOLOGICAL RISKS; LETHAL CONCENTRATIONS; MIXTURE EFFECTS; PERCENTILE CONTAMINATION RANGE;

DRUG PRODUCTS;

BEZAFIBRATE; CARBAMAZEPINE; CLOFIBRIC ACID; DICLOFENAC; DRUG; GEMFIBROZIL; IBUPROFEN; PARACETAMOL; SALICYLIC ACID; TOLFENAMIC ACID;

PHARMACEUTICAL INDUSTRY; RISK ASSESSMENT; TOXICITY; WASTEWATER; WATER TREATMENT;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL ANALYSIS; CHRONIC TOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DAPHNIA; ECOTOXICITY; EFFLUENT TOXICITY; LC 50; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTH KOREA; TOXICITY; TOXICITY TESTING; WASTE WATER MANAGEMENT; WATER CONTAMINATION;

ANIMALS; DAPHNIA; DRUG TOXICITY; ENVIRONMENTAL MONITORING; KOREA; LETHAL DOSE 50; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PHARMACEUTICAL PREPARATIONS; REPRODUCTION; RISK ASSESSMENT; SEWAGE; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL;

ASIA; EURASIA; FAR EAST; KOREA;

ANIMALIA; DAPHNIA; DAPHNIA MAGNA;

EID: 29744441163     PISSN: 07307268     EISSN: None     Source Type: Journal    
DOI: 10.1897/05-193R.1     Document Type: Article

References (33)

1. Sanderson H, Johnson DJ, Wilson CJ, Brain RA, Solomon KR. 2003. Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol Lett 144:383-395.
2. Ferrari B, Paxéus N, Giudice RL, Pollio A, Garric J. 2003. Ecotoxicological impact of pharmaceuticals found in treated waste-waters: Study of carbamazepine, clofbric acid, and diclofenac. Ecotoxicol Environ Saf 55:359-370.
3. Heberer T. 2002. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J Hydrol 266:175-189.
4. Doll TE, Frimmel FH. 2003. Fate of pharmaceuticals photodegradation by simulated solar UV-light. Chemosphere 52:1757-1769.
5. Ternes TA. 1998. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32:3245-3260.
6. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT 2002. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ Sci Technol 36:1202-1211.
7. Buser HR, Poiger T, Muller MD. 1998. Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: Rapid photodegradation in a lake. Environ Sci Technol 32:3449-3456.
8. Stumpf M, Ternes TA, Wilken RD, Rodrigues SV, Baumann W. 1999. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci Total Environ 225:135-141.
9. Ahrer W, Scherwenk E, Buchberger W. 2001. Determination of drug residues in water by the combination of liquid chromatography or capillary electrophoresis with electrospray mass spectrometry. J Chromatogr A 919:69-78.
10. Öllers S, Singer HP, Fässler P Müller SR. 2001. Simultaneous quantification of neutral and acidic pharmaceuticals and pesticides at the low-ng/L level in surface and waste water. J Chromatogr A 911:225-234.
11. Stumpf M, Ternes TA, Haberer K, Baumann W. 1998. Isolierung von ibuprofen-metaboliten and deren bedeutung als kontaminaten in der aquatischen Umwelt. Vom Wasser 91:291-303.
12. Buser HR, Poiger T, Muller MD. 1999. Occurrence and environmental behavior of the pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Technol 33:2529-2535.
13. Kosjek T, Heath E, Krbavcic A. 2005. Determination of nonsteroidal anti-inflammatory drug (NSAIDs) residues in water samples. Environ Int 31:679-685.
14. Sedlak DL, Pinkston KE. 2001. Factors affecting the concentrations of pharmaceuticals released to the aquatic environment. Water Resources Update 120:56-64.
15. Hirsch R, Ternes TA, Haberer K, Kratz KL. 1999. Occurrence of antibiotics in the aquatic environment. Sci Total Environ 225:109-118.
16. Ashton D, Hilton M, Thomas KV. 2004. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 333:167-184.
17. Miao X-S, Metcalfe CD. 2003. Determination of carbamazepine and its metabolites in aqueous samples using liquid chromatography-electrospray tandem mass spectrometry. Anal Chem 75:3731-3738.
18. Pedersen JA, Soliman M, Suffet IH. 2005. Human pharmaceuticals, hormones, and personal care product ingredients in runoff from agricultural fields irrigated with treated wastewater. J Agric Food Chem 53:1625-1632.
19. Gross B, Montgomery-Brown J, Naumann A, Reinhard M. 2004. Occurrence and fate of pharmaceuticals and alkylphenol ethoxylate metabolites in an effluent-dominated river and wetland. Environ Toxicol Chem 23:2074-2083.
20. Metcalfe CD, Koenig BG, Bennie DT, Servos M, Ternes TA, Hirsch R. 2003. Occurrence of neutral and acidic drugs in three effluents of Canadian sewage treatment plants. Environ Toxicol Chem 22:2872-2880.
21. Ternes TA, Meisenheimer M, Mcdowell D, Brauch HJ, Brigitte HG, Preuss G, William U, Zulei-Seibert N. 2002. Removal of pharmaceuticals during drinking water treatment. Environ Sci Technol 36:3855-3863.
22. U.S. Environmental Protection Agency. 1993. Method for measuring the acute toxicity of effluents and receiving waters to freshwater and marine organism. EPA/600/4-90/027F. Cincinnati, OH.
23. U.S. Environmental Protection Agency. 1994. Short-term methods for estimating the chronic toxicity of effluents and receiving waters to freshwater organisms. EPA/600/4-91/002. Cincinnati, OH.
24. U.S. Environmental Protection Agency. 1992. Framework for ecological risk assessment. EPA/630/R-92/001. Risk Assessment Forum, Washington, DC.
25. Commission of the European Communities. 1996. Technical guidance document in support of commission directive 93/67/EEC on risk assessment for new notified substances and commission regulation (EC) No 1488/94 on risk assessment for existing substances. Office for Official Publications of the European Communities, Luxembourg.
26. Organization for Economic Co-operation and Development. 1992. Report of the OECD workshop on the extrapolation of laboratory aquatic toxicity data to the real environment. Monograph 58. Paris, France.
27. Cleuvers M. 2003. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 142:185-195.
28. Halling-Sorensen B, Nielsen SN, Lanzky PF, Ingerslev F, Lutzhoft HCH, Jorgensen SE. 1998. Occurrence, fate and effect of pharmaceutical substances in the environment-A review. Chemosphere 36:357-393.
29. Adams C, Wang Y, Loftin K, Meyer M. 2002. Removal of antibiotics from surface and distilled water in conventional water treatment processes. J Environ Eng 128:253-260.
30. Boyd GR, Reemtsma H, Grimm DA, Mitra S. 2003. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA, and Ontario, Canada. Sci Total Environ 311:135-149.
31. Richardson ML, Bowron JM. 1985. The fate of pharmaceutical chemicals in the aquatic environment. J Pharm Pharmacol 37:1-12.
32. Poiger TH, Buser HR, Muller MD. 2001. Photodegradation of the pharmaceutical drug diclofenac in a lake: Pathway, field measurement, and mathematical modeling. Environ Toxicol Chem 20:256-263.
33. Howard PH, Meylan WM. 1997. Handbook of Physical Properties of Organic Chemicals. Lewis, Boca Raton, FL, USA.